• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多系统萎缩:诊断挑战及一种拟议的诊断算法。

Multiple system atrophy: Diagnostic challenges and a proposed diagnostic algorithm.

作者信息

Nandanwar Deepmala, Truong Daniel D

机构信息

The Parkinson and Movement Disorder Institute, 9940 Talbert Avenue, Fountain Valley, CA 92708, USA.

出版信息

Clin Park Relat Disord. 2024 Sep 18;11:100271. doi: 10.1016/j.prdoa.2024.100271. eCollection 2024.

DOI:10.1016/j.prdoa.2024.100271
PMID:39381077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11460479/
Abstract

Multiple system atrophy (MSA) is a heterogenous condition, presenting with core clinical features of autonomic dysfunction, parkinsonism, and/or cerebellar ataxia. The presence of alpha-synuclein glial cytoplasmic inclusion is the hallmark of MSA. It shares a common pathological origin with Parkinson's disease (PD) and Lewy body dementia (DLB) and they are collectively grouped as "synucleinopathies." The pathological synuclein protein is now well- recognized in skin biopsies of these patients. Besides the pathological findings, radiological investigation is a useful diagnostic tool. Brain MRI helps rule out other etiologies, and findings like the "Hot-cross bun" sign, "putaminal atrophy," and "infratentorial findings" can assist with the diagnosis of MSA. Cardiac MIBG scan, autonomic testing, urodynamic studies can help differentiate MSA from other conditions. Although diagnostic tools are available for MSA diagnosis, clarity is needed on when to use these tests. We suggest a diagnostic algorithm to navigate the use of these tests. However, this algorithm is not intended to replace the use of current MDS diagnostic criteria of MSA.

摘要

多系统萎缩(MSA)是一种异质性疾病,具有自主神经功能障碍、帕金森综合征和/或小脑共济失调等核心临床特征。α-突触核蛋白胶质细胞胞质内包涵体的存在是MSA的标志。它与帕金森病(PD)和路易体痴呆(DLB)有着共同的病理起源,它们被统称为“突触核蛋白病”。现在,在这些患者的皮肤活检中,病理性突触核蛋白已得到充分认识。除了病理检查结果外,影像学检查也是一种有用的诊断工具。脑部磁共振成像(MRI)有助于排除其他病因,像“热十字面包”征、“壳核萎缩”和“幕下表现”等结果可辅助MSA的诊断。心脏间碘苄胍(MIBG)扫描、自主神经功能测试、尿动力学研究有助于将MSA与其他疾病区分开来。虽然有用于MSA诊断的工具,但在何时使用这些检查方面仍需要明确。我们提出一种诊断算法来指导这些检查的使用。然而,该算法并非旨在取代当前MSA的多系统萎缩诊断标准(MDS)的使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12aa/11460479/e41be2ed5a4d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12aa/11460479/79563824691f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12aa/11460479/b1e0b8254b3b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12aa/11460479/e41be2ed5a4d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12aa/11460479/79563824691f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12aa/11460479/b1e0b8254b3b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12aa/11460479/e41be2ed5a4d/gr3.jpg

相似文献

1
Multiple system atrophy: Diagnostic challenges and a proposed diagnostic algorithm.多系统萎缩:诊断挑战及一种拟议的诊断算法。
Clin Park Relat Disord. 2024 Sep 18;11:100271. doi: 10.1016/j.prdoa.2024.100271. eCollection 2024.
2
Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.皮肤雪旺细胞中磷酸化的α-突触核蛋白:多系统萎缩的一个新生物标志物。
Brain. 2023 Mar 1;146(3):1065-1074. doi: 10.1093/brain/awac124.
3
Neuropathology and molecular diagnosis of Synucleinopathies.神经病理学和神经核蛋白病的分子诊断。
Mol Neurodegener. 2021 Dec 18;16(1):83. doi: 10.1186/s13024-021-00501-z.
4
Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.在突触核蛋白病中 123I-MIBG 闪烁显像与磷酸化α-突触核蛋白皮肤沉积物的比较。
Parkinsonism Relat Disord. 2020 Dec;81:48-53. doi: 10.1016/j.parkreldis.2020.10.016. Epub 2020 Oct 8.
5
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].帕金森病与路易体痴呆早期诊断的临床与病理研究
Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. doi: 10.5692/clinicalneurol.48.11.
6
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.皮肤活检中突触核蛋白病患者磷酸化α-突触核蛋白的检测。
JAMA. 2024 Apr 16;331(15):1298-1306. doi: 10.1001/jama.2024.0792.
7
The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.心血管自主神经衰竭在α-突触核蛋白病鉴别诊断中的作用。
Neurol Sci. 2022 Jan;43(1):187-198. doi: 10.1007/s10072-021-05746-6. Epub 2021 Nov 24.
8
Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.多系统萎缩变异的形态磁共振成像特征及其对鉴别诊断的影响。
Mov Disord. 2019 Jul;34(7):1041-1048. doi: 10.1002/mds.27669. Epub 2019 Mar 28.
9
[Multiple system atrophy].[多系统萎缩]
Psychol Neuropsychiatr Vieil. 2010 Sep;8(3):179-91. doi: 10.1684/pnv.2010.0212.
10
Diagnosing multiple system atrophy at the prodromal stage.在前驱期诊断多系统萎缩。
Clin Auton Res. 2020 Jun;30(3):197-205. doi: 10.1007/s10286-020-00682-5. Epub 2020 Mar 30.

本文引用的文献

1
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.皮肤活检中突触核蛋白病患者磷酸化α-突触核蛋白的检测。
JAMA. 2024 Apr 16;331(15):1298-1306. doi: 10.1001/jama.2024.0792.
2
Validation Study of the MDS Criteria for the Diagnosis of Multiple System Atrophy in the Mayo Clinic Brain Bank.梅奥诊所脑库中多系统萎缩诊断的MDS标准验证研究
Neurology. 2023 Dec 12;101(24):e2460-e2471. doi: 10.1212/WNL.0000000000207905. Epub 2023 Oct 10.
3
A Review on the Clinical Diagnosis of Multiple System Atrophy.
多系统萎缩的临床诊断述评
Cerebellum. 2023 Oct;22(5):825-839. doi: 10.1007/s12311-022-01453-w. Epub 2022 Aug 19.
4
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.α-突触核蛋白种子扩增检测在突触核蛋白病诊断中的应用:未来之路。
Neurology. 2022 Aug 2;99(5):195-205. doi: 10.1212/WNL.0000000000200878. Epub 2022 Jun 3.
5
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.运动障碍学会多系统萎缩诊断标准。
Mov Disord. 2022 Jun;37(6):1131-1148. doi: 10.1002/mds.29005. Epub 2022 Apr 21.
6
Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.突触核蛋白-1 研究:皮肤活检中磷酸化 α-突触核蛋白的检测用于突触核蛋白病的诊断。
Biomark Med. 2022 May;16(7):499-509. doi: 10.2217/bmm-2021-0646. Epub 2022 Mar 11.
7
Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis.DaTscan在疑似帕金森综合征患者中的临床应用:一项系统评价和荟萃分析。
NPJ Parkinsons Dis. 2021 May 24;7(1):43. doi: 10.1038/s41531-021-00185-8.
8
Laboratory-Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study Group.实验室支持的多系统萎缩:超越自主神经功能测试和影像学——MoDiMSA研究小组的系统评价
Mov Disord Clin Pract. 2021 Mar 10;8(3):322-340. doi: 10.1002/mdc3.13158. eCollection 2021 Apr.
9
Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atrophy Study Group.自主神经检测与影像学检查能否有助于多系统萎缩的早期诊断?运动障碍协会多系统萎缩研究组的系统评价与建议
Mov Disord Clin Pract. 2020 Sep 3;7(7):750-762. doi: 10.1002/mdc3.13052. eCollection 2020 Oct.
10
Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions.路易体痴呆的诊断标准:更新与未来方向。
J Mov Disord. 2020 Jan;13(1):1-10. doi: 10.14802/jmd.19052. Epub 2019 Nov 8.